Business Description
Bio Essence Corp
NAICS : 325412
SIC : 2834
ISIN : US09090C1053
Description
Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. It develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offers special formulated dietary supplements and medical food.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -2.04 | |||||
Debt-to-Equity | -1.42 | |||||
Debt-to-EBITDA | -3.42 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -10.31 | |||||
Beneish M-Score | 80.71 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.7 | |||||
3-Year EBITDA Growth Rate | -9.5 | |||||
3-Year EPS without NRI Growth Rate | -6.9 | |||||
3-Year FCF Growth Rate | -9.6 | |||||
3-Year Book Growth Rate | 6.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.05 | |||||
9-Day RSI | 36.6 | |||||
14-Day RSI | 42.1 | |||||
6-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | -33.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.31 | |||||
Quick Ratio | 0.31 | |||||
Days Inventory | 573.05 | |||||
Days Sales Outstanding | 26.29 | |||||
Days Payable | 233.6 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 3.84 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.61 | |||||
Operating Margin % | -320.85 | |||||
Net Margin % | -270.14 | |||||
FCF Margin % | -457.82 | |||||
ROA % | -33.72 | |||||
ROIC % | -19.48 | |||||
ROC (Joel Greenblatt) % | -44.5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 149.97 | |||||
EV-to-EBIT | -72.81 | |||||
EV-to-EBITDA | -78.67 | |||||
EV-to-Revenue | 222.21 | |||||
EV-to-FCF | -48.54 | |||||
Earnings Yield (Greenblatt) % | -1.37 | |||||
FCF Yield % | -2.82 |